Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midazolam oral solution for preoperative anxiolysis and sedation in adults
ChiCTR2300070925Phase 4Not yet recruiting
- Sponsor
- The Fourth Affiliated Hospital of Zhejiang University School of Medicine
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of midazolam in preoperative anxiety (2 arms), sponsored by The Fourth Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoint: Vital sign. Planned start May 2023; status: not yet recruiting.
02
Drugs
midazolam
03
Conditions
preoperative anxiety
Beyond the preview
Go deeper on ChiCTR2300070925.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300070925.